YENOM NOTICIAS
Noticias financieras organizadas para conectar titulares, símbolos, fuente, fecha y sentimiento con tu análisis y operativa.
Si escribes ticker, YENOM prioriza ese instrumento. Si lo dejas vacío puedes explorar el feed general o por tema.
Benzinga and Yahoo Finance LLC may earn commission or revenue on some items through the links below. Arm Holdings PLC CEO Rene Haas said artificial intelligence could help find a cure for cancer within our lifetime, but warned that chip sh…
Benzinga and Yahoo Finance LLC may earn commission or revenue on some items through the links below. Nvidia Corp's GPUs have become the backbone of artificial intelligence, but they won't be enough to determine the winners in AI-driven dru…
This article first appeared on GuruFocus. Cathie Wood's ARK Invest adjusted several technology holdings on Wednesday, adding to Broadcom while trimming its position in Advanced Micro Devices. ARK purchased 57,705 Broadcom shares across mul…
[Wall street.] bodrumsurf/iStock via Getty Images Shares of Generate Biomedicines (GENB [https://seekingalpha.com/symbol/GENB]), an AI-driven drug discovery company, advanced about 12% today. Shares traded at $19.81 in mid-afternoon tradin…
Generate Biomedicines stock jumps as post-IPO lock-up set to expire Proactive uses images sourced from Shutterstock Shares of Generate Biomedicines Inc (NASDAQ:GENB) jumped more than 20% on Tuesday as investors positioned ahead of the expi…
Nvidia (NVDA) disclosed a substantial new stake in SpaceX (SPCX) in its latest 13F filing, revealing ownership of roughly 122.76 million SPCX shares as of the end of the second quarter, led by CEO Jensen Huang's investment strategy. The po…
This article first appeared on GuruFocus. Nvidia (NASDAQ:NVDA) disclosed eight US-listed equity positions worth $63.44 billion as of June 30. The largest is Intel (NASDAQ:INTC), at 214,776,632 shares worth $29.99 billion, which is roughly…
[Nvidia Corporate Office Logo Santa Clara California] Robert Way * Nvidia (NVDA [https://seekingalpha.com/symbol/NVDA]) filed [https://seekingalpha.com/filing/309956005] its 13F quarterly holding report on Friday and disclosed it owned a b…
Generate Biomedicines (NASDAQ: GENB) is one of the top five largest holdings of Nvidia (NASDAQ: NVDA), run by CEO Jensen Huang. Let that sink in for a moment. The largest publicly traded company by market capitalization has roughly $10.4 m…
(RTTNews) - Eupraxia Pharmaceuticals Inc. (EPRX), a clinical-stage biotechnology company, announced several leadership changes within the company to support its upcoming planned phase of clinical and commercial growth. The company appointe…
Cathie Wood's ARK Invest's largest purchase during the last week by value was Elon Musk's Space Exploration Technologies (SPCX [https://seekingalpha.com/symbol/SPCX]), adding a combined 349K shares across ARKK, ARKQ, ARKW and ARKX for ~$52…
Key Points The chipmaker has active interests in the healthcare market, including a partnership with Eli Lilly and an investment in small biotech Generate Biomedicines. Nvidia CEO Jensen Huang sees a powerful intersection between health an…
Nvidia (NASDAQ: NVDA) is known as one of the most advanced makers of chips powering the breakthroughs in artificial intelligence (AI). But what some people may not know is that Nvidia is also an investor in other companies. Among its inves…
Cathie Wood, head of Ark Investment Management, is known for buying her favorite tech stocks during market pullbacks. That's exactly what she just did, adding shares of an AI stock after a sharp selloff. In 2025, the flagship Ark Innovatio…
Key Points Cathie Wood added to her positions in Space Exploration, Bullish, and Generate Biomedicines on Monday. The three stocks have gone public over the past year. The addition of SpaceX to the Nasdaq-100 on Tuesday should result in a…
Cathie Wood didn't let last week's holiday-abridged run lull her into slumber. She was actively making moves for her Ark Invest ETFs on Monday. She made a few sells, but let's talk about Ark's purchases. Ark's co-founder, CEO, and chief in…
Cathie Wood, head of Ark Investment Management, is known for betting on disruptive technology companies, and investors closely watch every move she makes. Sometimes, she'll even buy tech stocks on the way up — and that's what she just did,…
This article first appeared on GuruFocus. Cathie Wood's ARK Invest increased its exposure to artificial intelligence, digital assets and next-generation healthcare during the week of June 22 to 26, while reducing positions in streaming and…
Key Points Artificial intelligence technology giant Nvidia owns a handful of promising stocks. One of these holdings is helping lead the charge of change for an industry that could use a cost-reducing revamp. Although this name poses above…
Collaboration combines Saudi Arabia's national health data capabilities with Flagship's life sciences and AI-enabled innovation expertise to accelerate precision medicine, scientific discovery, and biomedical ecosystem development in suppo…
Generate Biomedicines, Inc. (NASDAQ:GENB) is one of the 12 Best AI Drug Discovery Stocks Hedge Funds Are Loading Up On. On May 14, Morgan Stanley increased its price objective on Generate Biomedicines, Inc. (NASDAQ:GENB) to $22 from $20. T…
BeOne Medicines (NASDAQ:ONC) is one of the most promising long-term stocks to buy according to analysts. On June 1, BeOne presented new clinical data at the 2026 ASCO Annual Meeting, highlighting accelerated progress across three high-prio…
Key Points HarbourVest initiated 1,722,210 shares of Generate Biomedicines last quarter; the estimated trade size was $21.03 million based on quarterly average prices. The quarter-end position value increased by $21.53 million, reflecting…
On May 15, 2026, HarbourVest Partners disclosed a new position in Generate Biomedicines(NASDAQ:GENB), acquiring 1,722,210 shares in the first quarter. The estimated transaction value is $21.03 million, based on quarterly average pricing. W…
SOMERVILLE, Mass., May 28, 2026 /PRNewswire/ -- Generate Biomedicines, Inc. (NASDAQ: GENB) today announced that it intends to participate in the Goldman Sachs Global Healthcare Conference on Monday, June 8, 2026.Generate:Biomedicines Logo…
When chip giant Nvidia (NVDA) shows interest in any company, analysts and investors take note. According to Nvidia’s most recent 13F filing, the company now owns 833,325 shares of AI biotech company Generate Biomedicines (GENB), with the p…
Key Points Interested in NVIDIA Corporation? Here are five stocks we like better. NVIDIA has been making multi-billion-dollar deals left and right as the company looks to strengthen its AI supply chain However, several recent investments d…
Generate Biomedicines, Inc. (NASDAQ:GENB) is one of the best low priced biotech stocks to invest in. On April 13, H.C. Wainwright initiated coverage of Generate Biomedicines, Inc. (NASDAQ:GENB) with a Buy rating, setting a $16 price target…
Cathie Wood seems to always be making market moves. The founder and CEO of Ark Invest publishes her transactions at the end of every trading day, and that gives us all a great way to track one of the most widely followed growth investors.…
Health care stocks rose late Friday afternoon, with the NYSE Health Care Index adding 1.3% and the S PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premium n…
This story was originally published on BioPharma Dive. To receive daily news and insights, subscribe to our free daily BioPharma Dive newsletter. AI drug discovery specialist Generate Biomedicines has raised $400 million in the year’s larg…